Profile
Lin Ni is currently the Managing Director at 6 Dimensions Capital since 2017 and an Independent Non-Executive Director at TenNor Therapeutics Suzhou Ltd. starting in 2025.
Former positions include Managing Director at Frontline Bioventures, Director at Shanghai Ark Biopharmaceutical Co., Ltd. in 2021, and Non-Executive Director at Edding Genor Group Holdings Ltd. from 2021 to 2022.
Education includes a doctorate degree from Osaka University conferred in 2009.
Lin Ni active positions
| Companies | Position | Start |
|---|---|---|
| TENNOR THERAPEUTICS (SUZHOU) LIMITED | Director/Board Member | 08/07/2025 |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Private Equity Investor | 18/05/2017 |
Former positions of Lin Ni
| Companies | Position | End |
|---|---|---|
| EDDING GENOR GROUP HOLDINGS LIMITED | Director/Board Member | 29/07/2022 |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Director/Board Member | 18/05/2017 |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Director/Board Member | - |
Training of Lin Ni
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Osaka University
Osaka University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontline Bioventures
Frontline Bioventures Investment ManagersFinance Acts as an alternative investment manager | Finance |
6 Dimensions Capital
6 Dimensions Capital Investment ManagersFinance 6 Dimensions Capital invests in early and growth stage companies in China, the U.S. and globally. The firm focuses on sectors such as biologics, small molecules, medical devices, diagnostics, medical services and healthcare IT. | Finance |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in biopharmaceutical services | Health Technology |
TenNor Therapeutics Suzhou Ltd.
TenNor Therapeutics Suzhou Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which engages in discovery, development and commercialization of therapies for bacterial infections and metabolism | Health Technology |
Genor Biopharma Holdings Ltd.
Genor Biopharma Holdings Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes oncology and autoimmune drugs | Health Technology |
- Stock Market
- Insiders
- Lin Ni
















